Skip to main content
. 2017 Sep 1;11(9):TC06–TC09. doi: 10.7860/JCDR/2017/28183.10535

[Table/Fig-1]:

Age distribution of study group.

Age
(in years)
Immunocompromised Group
(n=30)
Immunocompetent Group
(n=30)
Total
No.(%age) No.(%age) No.(%age)
20-40 11(36.7%) 9(30.0%) 20(33.3%)
41-60 15(50.0%) 11(36.7%) 26(43.3%)
>60 4(13.3%) 10(33.3%) 14(23.3%)